Compare FLWS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLWS | ORMP |
|---|---|---|
| Founded | 1976 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.3M | 197.6M |
| IPO Year | 1999 | 2010 |
| Metric | FLWS | ORMP |
|---|---|---|
| Price | $2.68 | $4.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 383.7K | 152.9K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 32.59 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | ★ $1,151,921,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.72 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $2.41 | $2.09 |
| 52 Week High | $7.10 | $5.47 |
| Indicator | FLWS | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 32.32 | 47.15 |
| Support Level | $2.41 | $4.54 |
| Resistance Level | $4.32 | $5.01 |
| Average True Range (ATR) | 0.23 | 0.15 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 26.12 | 36.14 |
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.